As of May 22
| +0.51 / +2.52%|
The 6 analysts offering 12-month price forecasts for Depomed Inc have a median target of 27.00, with a high estimate of 34.00 and a low estimate of 25.50. The median estimate represents a +30.06% increase from the last price of 20.76.
The current consensus among 6 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.